Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 9 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HIY8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 208 | 212 | PF00656 | 0.614 |
CLV_C14_Caspase3-7 | 226 | 230 | PF00656 | 0.369 |
CLV_NRD_NRD_1 | 325 | 327 | PF00675 | 0.737 |
CLV_PCSK_FUR_1 | 117 | 121 | PF00082 | 0.472 |
CLV_PCSK_KEX2_1 | 119 | 121 | PF00082 | 0.446 |
CLV_PCSK_KEX2_1 | 218 | 220 | PF00082 | 0.558 |
CLV_PCSK_KEX2_1 | 324 | 326 | PF00082 | 0.734 |
CLV_PCSK_KEX2_1 | 334 | 336 | PF00082 | 0.755 |
CLV_PCSK_PC1ET2_1 | 119 | 121 | PF00082 | 0.472 |
CLV_PCSK_PC1ET2_1 | 218 | 220 | PF00082 | 0.558 |
CLV_PCSK_PC1ET2_1 | 324 | 326 | PF00082 | 0.750 |
CLV_PCSK_PC7_1 | 115 | 121 | PF00082 | 0.514 |
CLV_PCSK_SKI1_1 | 261 | 265 | PF00082 | 0.368 |
CLV_PCSK_SKI1_1 | 301 | 305 | PF00082 | 0.682 |
CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.451 |
DEG_APCC_DBOX_1 | 231 | 239 | PF00400 | 0.603 |
DEG_APCC_DBOX_1 | 68 | 76 | PF00400 | 0.586 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.444 |
DEG_SCF_FBW7_2 | 303 | 308 | PF00400 | 0.734 |
DOC_MAPK_gen_1 | 218 | 224 | PF00069 | 0.503 |
DOC_MAPK_gen_1 | 261 | 267 | PF00069 | 0.485 |
DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.732 |
DOC_USP7_MATH_1 | 276 | 280 | PF00917 | 0.582 |
DOC_USP7_MATH_1 | 46 | 50 | PF00917 | 0.636 |
DOC_WW_Pin1_4 | 301 | 306 | PF00397 | 0.698 |
LIG_Actin_WH2_2 | 231 | 248 | PF00022 | 0.591 |
LIG_Clathr_ClatBox_1 | 195 | 199 | PF01394 | 0.598 |
LIG_eIF4E_1 | 260 | 266 | PF01652 | 0.553 |
LIG_FHA_1 | 123 | 129 | PF00498 | 0.480 |
LIG_FHA_1 | 46 | 52 | PF00498 | 0.649 |
LIG_FHA_1 | 74 | 80 | PF00498 | 0.536 |
LIG_FHA_1 | 88 | 94 | PF00498 | 0.368 |
LIG_LIR_Gen_1 | 163 | 173 | PF02991 | 0.491 |
LIG_LIR_Gen_1 | 311 | 320 | PF02991 | 0.698 |
LIG_LIR_Nem_3 | 163 | 169 | PF02991 | 0.492 |
LIG_LIR_Nem_3 | 257 | 263 | PF02991 | 0.468 |
LIG_LIR_Nem_3 | 311 | 317 | PF02991 | 0.674 |
LIG_LRP6_Inhibitor_1 | 217 | 223 | PF00058 | 0.561 |
LIG_NRP_CendR_1 | 334 | 337 | PF00754 | 0.718 |
LIG_SH2_CRK | 260 | 264 | PF00017 | 0.482 |
LIG_SH2_CRK | 314 | 318 | PF00017 | 0.706 |
LIG_SH2_STAT3 | 38 | 41 | PF00017 | 0.766 |
LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.741 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.588 |
LIG_TRAF2_1 | 64 | 67 | PF00917 | 0.619 |
LIG_TRAF2_1 | 98 | 101 | PF00917 | 0.573 |
LIG_TYR_ITIM | 258 | 263 | PF00017 | 0.510 |
LIG_UBA3_1 | 264 | 272 | PF00899 | 0.493 |
MOD_CK1_1 | 184 | 190 | PF00069 | 0.536 |
MOD_CK2_1 | 276 | 282 | PF00069 | 0.592 |
MOD_CK2_1 | 95 | 101 | PF00069 | 0.571 |
MOD_Cter_Amidation | 322 | 325 | PF01082 | 0.707 |
MOD_GlcNHglycan | 14 | 17 | PF01048 | 0.704 |
MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.511 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.601 |
MOD_GlcNHglycan | 250 | 253 | PF01048 | 0.535 |
MOD_GlcNHglycan | 329 | 332 | PF01048 | 0.653 |
MOD_GlcNHglycan | 48 | 51 | PF01048 | 0.647 |
MOD_GSK3_1 | 180 | 187 | PF00069 | 0.415 |
MOD_GSK3_1 | 206 | 213 | PF00069 | 0.512 |
MOD_GSK3_1 | 244 | 251 | PF00069 | 0.519 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.742 |
MOD_GSK3_1 | 297 | 304 | PF00069 | 0.627 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.607 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.599 |
MOD_N-GLC_1 | 87 | 92 | PF02516 | 0.442 |
MOD_NEK2_1 | 180 | 185 | PF00069 | 0.588 |
MOD_NEK2_1 | 245 | 250 | PF00069 | 0.552 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.572 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.496 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.272 |
MOD_PIKK_1 | 123 | 129 | PF00454 | 0.600 |
MOD_PIKK_1 | 93 | 99 | PF00454 | 0.530 |
MOD_PKA_2 | 181 | 187 | PF00069 | 0.602 |
MOD_Plk_1 | 87 | 93 | PF00069 | 0.504 |
MOD_Plk_4 | 276 | 282 | PF00069 | 0.540 |
MOD_ProDKin_1 | 301 | 307 | PF00069 | 0.700 |
MOD_SUMO_rev_2 | 253 | 263 | PF00179 | 0.459 |
MOD_SUMO_rev_2 | 308 | 313 | PF00179 | 0.720 |
MOD_SUMO_rev_2 | 78 | 87 | PF00179 | 0.498 |
MOD_SUMO_rev_2 | 96 | 105 | PF00179 | 0.370 |
TRG_DiLeu_BaEn_1 | 54 | 59 | PF01217 | 0.624 |
TRG_DiLeu_BaEn_4 | 164 | 170 | PF01217 | 0.339 |
TRG_ENDOCYTIC_2 | 260 | 263 | PF00928 | 0.483 |
TRG_ENDOCYTIC_2 | 314 | 317 | PF00928 | 0.666 |
TRG_ER_diArg_1 | 114 | 117 | PF00400 | 0.513 |
TRG_ER_diArg_1 | 334 | 337 | PF00400 | 0.768 |
TRG_Pf-PMV_PEXEL_1 | 130 | 134 | PF00026 | 0.484 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PC73 | Leptomonas seymouri | 67% | 100% |
A0A0S4J6B5 | Bodo saltans | 31% | 71% |
A0A1X0P000 | Trypanosomatidae | 31% | 93% |
A0A3S7X2L2 | Leishmania donovani | 88% | 100% |
A4I4P2 | Leishmania infantum | 88% | 100% |
C9ZLD3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 87% |
E9AE45 | Leishmania major | 86% | 100% |
E9ALP0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
V5BKZ3 | Trypanosoma cruzi | 30% | 93% |